The director of the Singular Research Center in Molecular Medicine and Chronic Diseases of the USC (Cimus), Mabel Loza, defended on Thursday "the value of the stable structures of collaboration between research, health system and industry, to accelerate the response to the great health challenges".
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The director of the Singular Research Center in Molecular Medicine and Chronic Diseases of the USC (Cimus), Mabel Loza, defended on Thursday "the value of the stable structures of collaboration between research, health system and industry, to accelerate the response to the great health challenges".